Browse 24936 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
January 17th, 2023 |
Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) |
Centers for Disease Control and Prevention ERA |
January 20th, 2023 |
Miner Safety and Health Training Program - Western United States |
Centers for Disease Control and Prevention ERA |
September 27th, 2022 |
HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional) |
National Institutes of Health |
December 5th, 2022 |
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
December 5th, 2022 |
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 12th, 2023 |
BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
October 20th, 2022 |
More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional) |
National Institutes of Health |
August 31st, 2022 |
Tribal Self-Governance Planning Cooperative Agreement Program |
Indian Health Service |
August 31st, 2022 |
Tribal Self-Governance Negotiation Cooperative Agreement Program |
Indian Health Service |
September 19th, 2022 |
Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed) |
National Institutes of Health |
January 13th, 2023 |
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
October 6th, 2022 |
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
October 6th, 2022 |
Regenerative Medicine Innovation Projects (RMIP) Investigator- Initiated Studies (Collaborative U01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 6th, 2022 |
Regenerative Medicine Innovation Projects (RMIP) Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) |
National Institutes of Health |
September 25th, 2025 |
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) |
National Institutes of Health |
October 13th, 2022 |
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed) |
National Institutes of Health |
October 13th, 2022 |
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed) |
National Institutes of Health |
October 17th, 2024 |
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
August 1st, 2022 |
DEGRA Follow-on/Djibouti Basic Education Activity |
Ethiopia USAID Addis Ababa |
August 8th, 2022 |
USAID/Ethiopia Empowering Community Activity |
Ethiopia USAID Addis Ababa |
|
February 17th, 2023 |
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
February 17th, 2023 |
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
January 9th, 2023 |
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 2nd, 2023 |
HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Not Allowed) |
National Institutes of Health |
May 8th, 2023 |
Overdose Data to Action: Limiting Overdose through Collaborative Actions in Localities (OD2A: LOCAL) |
Centers for Disease Control NCIPC |
April 17th, 2023 |
Building capacity for implementing evidence-based epilepsy self-management supports in health care settings |
Centers for Disease Control NCCDPHP |
February 2nd, 2023 |
HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional) |
National Institutes of Health |
October 19th, 2022 |
Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional) |
National Institutes of Health |
October 5th, 2022 |
Impact of the Microbiome-Gut-Brain Axis on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
November 22nd, 2022 |
Harnessing Technologies to Support Oral Health Promotion and Management Outside the Dental Setting (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
December 1st, 2022 |
National Coordinating Center for the George M. OBrien Kidney National Resource Centers (U24 - Clinical Trial Not Allowed) |
National Institutes of Health |
December 1st, 2022 |
George M. O'Brien Kidney National Resource Centers (U54 - Clinical Trial Not Allowed) |
National Institutes of Health |
November 8th, 2022 |
New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed) |
National Institutes of Health |
September 6th, 2022 |
PEPFAR Community Led Monitoring (CLM)-Zambia |
US Mission to Zambia |
November 15th, 2022 |
Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only) |
National Institutes of Health |
June 26th, 2025 |
NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
September 30th, 2022 |
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2025 |
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) |
National Institutes of Health |
May 22nd, 2023 |
Annual Program Statement - Public Diplomacy Small Grants |
US Mission to India |
July 15th, 2024 |
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) |
National Institutes of Health |